DR. RICHARD AKROMIS

PA-CReal-Time Hydrated
Practice Location: OBERLIN, KS 67749
NPI Number: 1649700295
LIFETIME INDUSTRY VALUE
$606
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AKROMIS is a verified Physician Assistant practitioner based in OBERLIN, KS.

Between 2021 and 2025, Dr. AKROMIS had an overall industry promotional and research financial footprint of $606 as recorded in the federal CMS Open Payments database.

  • $606 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. AKROMIS's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $147 (representing 24.2% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$335$167$0$362021$1012022$982023$3352024$362025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS
Rank 1
$147
24.2%
OTSUKA AMERICA PHARMACEUTICAL
Rank 2
$127
20.9%
SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US
Rank 3
$97
16%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.